A Geographically Weighted Cost-effectiveness Analysis of Newborn Cytomegalovirus Screening.
Paul M LantosSoren GanttMark JankoFrancois DionneSallie R PermarKaren FowlerPublished in: Open forum infectious diseases (2024)
Universal newborn CMV screening is cost-effective regardless of underlying CMV prevalence and is the preferred strategy to reduce morbidity from congenital CMV.